Relationships among allergic rhinitis, asthma, and chronic rhinosinusitis

American Journal of Rhinology and Allergy

Volumn 30, Issue 1, 2016, Pages 44-47

  Rosati, Mariel G ^a   Peters, Anju T ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DUPILUMAB; OMALIZUMAB;

ALLERGIC RHINITIS; ARTICLE; ASTHMA; COMORBIDITY; CONTROLLED CLINICAL TRIAL (TOPIC); DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOSCOPIC SINUS SURGERY; EOSINOPHIL COUNT; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNOTHERAPY; LUNG FUNCTION; PEAK EXPIRATORY FLOW; PHASE 1 CLINICAL TRIAL (TOPIC); PREVALENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RHINOSINUSITIS; CHRONIC DISEASE; DISEASE COURSE; RHINITIS, ALLERGIC; SINUSITIS; UNITED STATES;

ASTHMA; CHRONIC DISEASE; COMORBIDITY; DISEASE PROGRESSION; HUMANS; PREVALENCE; RHINITIS, ALLERGIC; SINUSITIS; UNITED STATES;

EID: 84959574101     PISSN: 19458924     EISSN: 19458932     Source Type: Journal    
DOI: 10.2500/ajra.2016.30.4252     Document Type: Article

References (41)

1. Shashy RG, Moore EJ, and Weaver A. Prevalence of the chronic sinusitis diagnosis in Olmsted County, Minnesota. Arch Otolaryngol Head Neck Surg 130:320-323, 2004.
2. Halawi AM, Smith SS, and Chandra RK. Chronic rhinosinusitis: Epidemiology and cost. Allergy Asthma Proc 34:328-334, 2013.
3. Sedaghat AR, Phipatanakul W, and Cunningham MJ. Characterization of aeroallergen sensitivities in children with allergic rhinitis and chronic rhinosinusitis. Allergy Rhinol (Providence) 5:143-145, 2014.
4. Gutman M, Torres A, Keen KJ, and Houser SM. Prevalence of allergy in patients with chronic rhinosinusitis. Otolaryngol Head Neck Surg 130:545-552, 2004.
5. Tan BK, Zirkle W, Chandra RK, et al. Atopic profile of patients failing medical therapy for chronic rhinosinusitis. Int Forum Allergy Rhinol 1:88-94, 2011.
6. Kennedy DW. Prognostic factors, outcomes and staging in ethmoid sinus surgery. Laryngoscope 102(pt. 2 suppl.57):1-18, 1992.
7. Emanuel IA, and Shah SB. Chronic rhinosinusitis: Allergy and sinus computed tomography relationships. Otolaryngol Head Neck Surg 123:687-691, 2000.
8. Tan BK, Chandra RK, Pollak J, et al. Incidence and associated premorbid diagnoses of patients with chronic rhinosinusitis. J Allergy Clin Immunol 131:1350-1360, 2013.
9. Lee TJ, Liang CW, Chang PH, and Huang CC. Risk factors for protracted sinusitis in pediatrics after endoscopic sinus surgery. Auris Nasus Larynx 36:655-660, 2009.
10. Hoover GE, Newman LJ, Platts-Mills TA, et al. Chronic sinusitis: Risk factors for extensive disease. J Allergy Clin Immunol 100:185-191, 1997.
11. Newman LJ, Platts-Mills TA, Phillips CD, et al. Chronic sinusitis. Relationship of computed tomographic findings to allergy, asthma, and eosinophilia. JAMA 271:363-367, 1994.
12. Batra PS, Tong L, and Citardi MJ. Analysis of comorbidities and objective parameters in refractory chronic rhinosinusitis. Laryngoscope 123(suppl. 7):S1-S11, 2013.
13. Ramadan HH, Fornelli R, Ortiz AO, and Rodman S. Correlation of allergy and severity of sinus disease. Am J Rhinol 13:345-347, 1999.
14. Robinson S, Douglas R, and Wormald PJ. The relationship between atopy and chronic rhinosinusitis. Am J Rhinol 20:625-628, 2006.
15. Pearlman AN, Chandra RK, Chang D, et al. Relationships between severity of chronic rhinosinusitis and nasal polyposis, asthma, and atopy. Am J Rhinol Allergy 23:145-148, 2009.
16. DeYoung K, Wentzel JL, Schlosser RJ, et al. Systematic review of immunotherapy for chronic rhinosinusitis. Am J Rhinol Allergy 28:145-150, 2014.
17. Jarvis D, Newson R, Lotvall J, et al. Asthma in adults and its association with chronic rhinosinusitis: The GA2LEN survey in Europe. Allergy 67:91-98, 2012.
18. Bresciani M, Paradis L, Des Roches A, et al. Rhinosinusitis in severe asthma. J Allergy Clin Immunol 107:73-80, 2001.
19. Ten Brinke A, Grootendorst DC, Schmidt JT, et al. Chronic sinusitis in severe asthma is related to sputum eosinophilia. J Allergy Clin Immunol 109:621-626, 2002.
20. Ek A, Middelveld RJ, Bertilsson H, et al. Chronic rhinosinusitis in asthma is a negative predictor of quality of life: Results from the Swedish GA (2) LEN survey. Allergy 68:1314-1321, 2013.
21. Moore WC, Bleecker ER, Curran-Everett D, et al. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. J Allergy Clin Immunol 119:405-413, 2007.
22. Ten Brinke A, Sterk PJ, Masclee AA, et al. Risk factors of frequent exacerbations in difficult-to-treat asthma. Eur Respir J 26:812-818, 2005.
23. Ivanova JI, Bergman R, Birnbaum HG, et al. Effect of asthma exacerbations on health care costs among asthmatic patients with moderate and severe persistent asthma. J Allergy Clin Immunol 129:1229-1235, 2012.
24. Lin DC, Chandra RK, Tan BK, et al. Association between severity of asthma and degree of chronic rhinosinusitis. Am J Rhinol Allergy 25:205-208, 2011.
25. American Lung Association-Asthma Clinical Research Centers' Writing Committee, Dixon AE, Castro M, et al. Efficacy of nasal mometasone for the treatment of chronic sinonasal disease in patients with inadequately controlled asthma. J Allergy Clin Immunol 135:701-709. e5, 2015.
26. Peters AT, Spector S, Hsu J, et al. Diagnosis and management of rhinosinusitis: A practice parameter update. Ann Allergy Asthma Immunol 113:347-385, 2014.
27. Palmer JN, Conley DB, Dong RG, et al. Efficacy of endoscopic sinus surgery in the management of patients with asthma and chronic sinusitis. Am J Rhinol 15:49-53, 2001.
28. Ikeda K, Tanno N, Tamura G, et al. Endoscopic sinus surgery improves pulmonary function in patients with asthma associated with chronic sinusitis. Ann Otol Rhinol Laryngol 108:355-359, 1999.
29. Ragab S, Scadding GK, Lund VJ, and Saleh H. Treatment of chronic rhinosinusitis and its effects on asthma. Eur Respir J 28:68-74, 2006.
30. Haldar P, Brightling CE, Hargadon B, et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med 360:973-984, 2009.
31. Pavord ID, Korn S, Howarth P, et al. Mepolizumab for severe eosinophilic asthma (DREAM): A multicentre, double-blind, placebo-controlled trial. Lancet 380:651-659, 2012.
32. Nair P, Pizzichini MM, Kjarsgaard M, et al. Mepolizumab for prednisonedependent asthma with sputum eosinophilia. N Engl J Med 360:985-993, 2009.
33. Gevaert P, Van Bruaene N, Cattaert T, et al. Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis. J Allergy Clin Immunol 128:989-995. e1-e8, 2011.
34. Castro M, Mathur S, Hargreave F, et al. Reslizumab for poorly controlled, eosinophilic asthma: A randomized, placebo-controlled study. Am J Respir Crit Care Med 184:1125-1132, 2011.
35. Castro M, Zangrilli J, Wechsler ME, et al. Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: Results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials. Lancet Respir Med 3:355-366, 2015.
36. Gevaert P, Lang-Loidolt D, Lackner A, et al. Nasal IL-5 levels determine the response to anti-IL-5 treatment in patients with nasal polyps. J Allergy Clin Immunol 118:1133-1141, 2006.
37. Laviolette M, Gossage DL, Gauvreau G, et al. Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia. J Allergy Clin Immunol 132:1086-1096. e5, 2013.
38. Busse WW, Katial R, Gossage D, et al. Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti-IL-5 receptor alpha antibody, in a phase I study of subjects with mild asthma. J Allergy Clin Immunol 125:1237-1244. e2, 2010.
39. Castro M, Wenzel SE, Bleecker ER, et al. Benralizumab, an antiinterleukin 5 receptor alpha monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: A phase 2b randomised dose-ranging study. Lancet Respir Med 2:879-890, 2014.
40. Wenzel S, Ford L, Pearlman D, et al. Dupilumab in persistent asthma with elevated eosinophil levels. N Engl J Med 368:2455-2466, 2013.
41. Gevaert P, Calus L, Van Zele T, et al. Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma. J Allergy Clin Immunol 131:110-116. e1, 2013.